Cote d'Ivoire vs Nepal: Access to anti-retroviral drugs, male (%)
Cote d'Ivoire
69.0%
in 2024
Nepal
71.0%
in 2024
Cote d'Ivoire rank
72nd
Nepal rank
69th
Access to anti-retroviral drugs, male (%) over time
- Cote d'Ivoire
- Nepal
How they compare
Nepal currently reports 71.0% against 69.0% in Cote d'Ivoire, a difference of 2.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Nepal ahead.
Cote d'Ivoire ranks 72nd and Nepal ranks 69th of 141 countries.
Cote d'Ivoire has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 1.6% | 1.8% | Cote d'Ivoire |
| 2010s | 28.6% | 24.5% | 4.1% | Cote d'Ivoire |
| 2020s | 61.2% | 60.4% | 0.8% | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Cote d'Ivoire or Nepal?
- Nepal, at 71.0% against 69.0% in Cote d'Ivoire as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Cote d'Ivoire and Nepal?
- 2.0%, with Nepal ahead.
- How many years of comparable data are there for Cote d'Ivoire and Nepal?
- 25 years are reported by both, from 2000 to 2024.
- How do Cote d'Ivoire and Nepal rank globally for access to anti-retroviral drugs, male?
- Cote d'Ivoire ranks 72nd and Nepal ranks 69th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.